Financials
- Market Capitalization 11.41 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
33.02
市销率
3.64
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 819 | SMMT Summit Therapeutics Inc. - Common Stock | 15.55 USD | +1.63% | -2.14% | +7.69% | -21.70% | 12.07 B USD | ||
| 827 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.59 USD | +3.20% | -6.52% | -7.37% | +80.94% | 12.12 B USD | ||
| 859 | TECH Bio-Techne Corp - Common Stock | 71.19 USD | -0.24% | +0.72% | +28.71% | +34.35% | 11.15 B USD | ||
| 876 | ABVX Abivax SA - American Depositary Shares | 135.44 USD | -0.40% | -6.41% | +35.98% | +1404.89% | 10.64 B USD |